SCHEMBL2113453

SCHEMBL2113453

CC(C)(C)OC(=O)Nc1cccc(CC2CC(NC(=O)OC(C)(C)C)CC2O)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM1A O60341 1/20 0.38
MAOB P27338 1/20 0.38
EPHX2 P34913 1/20 0.37
DRD2 P14416 4/20 0.36
REN P00797 1/20 0.35
CCR2 P41597 1/20 0.35
CKS1B P61024 1/20 0.35
SKP1 P63208 1/20 0.35
SKP2 Q13309 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
KIF18A Q8NI77 1/20 0.35
JAK1 P23458 1/20 0.35
BTK Q06187 3/20 0.34
PARP1 P09874 1/20 0.34
TGFBR1 P36897 1/20 0.34
METAP1 P53582 1/20 0.34
KCNA3 P22001 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2600836 1.00 KMT2A (0.41) KMT2AL3MBTL1KDM1AMAOBEPHX2
SCHEMBL2600838 1.00 KMT2A (0.41) KMT2AL3MBTL1KDM1AMAOBEPHX2
SCHEMBL2600837 1.00 KMT2A (0.41) KMT2AL3MBTL1KDM1AMAOBEPHX2
SCHEMBL2600839 0.84 NOS1 (0.38) KMT2AL3MBTL1KDM1AMAOBEPHX2
SCHEMBL12385615 0.82 CCR2 (0.37) KMT2AL3MBTL1CCR2SIRT1TGFBR1
SCHEMBL2600835 0.81 KMT2A (0.39) KMT2AL3MBTL1KDM1AMAOBEPHX2
SCHEMBL2114654 0.81 KMT2A (0.39) KMT2AL3MBTL1KDM1AMAOBEPHX2
SCHEMBL2600825 0.81 CCR2 (0.36) RENCCR2
SCHEMBL2600822 0.81 CCR2 (0.36) RENCCR2
SCHEMBL2113649 0.81 CCR2 (0.36) RENCCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158658-B2 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase NORTHWESTERN UNIVERSITY (US) 2012-04-17 US disclosed
US-7994326-B2 For treatment of various forms of neurodegeneration, including that from stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease NORTHWESTERN UNIVERSITY (US) 2011-08-09 US disclosed